MedPath

Retrospective Study of Intracerebral Hemorrhage Patients in Hospital Parc Taulí

Completed
Conditions
Intracerebral Hemorrhage
Interventions
Other: No intervention
Registration Number
NCT04877405
Lead Sponsor
Universitat Autonoma de Barcelona
Brief Summary

This is a retrospective observational study to investigate the clinical, analytical and neuroimaging data generated during routine clinical management of intracerebral hemorrhage. The study will review the data from about 500 patients attended during the last ten years in the Neurology Department of Hospital Parc Taulí de Sabadell.

The aim is to measure the size of the lesion in neuroimage (TC and MRI), the edema, the alterations in diffusion weighted images and to correlate this data with clinical parameters and analytical measurements. With this approach investigators plan to investigate the incidence of hematoma growth, the role of perilesional edema and diffusion changes, and the relation between neuroimaging findings and clinical outcome. The study also try to establish significant correlations between clinical and analytical data, the clinical outcome and and the magnitude of changes in neuroimaging.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
137
Inclusion Criteria
  • Patients who have been attended at the Hospital Parc Taulí for the last 10 years after presenting an intraparenchymal hemorrhage.
  • The patients have had to undergo a computed tomography at the admission and a cranial magnetic resonance during the hospitalization in the time course specified in point in the protocol
  • The patients must present in their clinical story the analytical determinations detailed in the protocol.
Exclusion Criteria
  • Intracerebral hemorrhage secondary to head trauma
  • Intracerebral hemorrhage secondary to neoplasm

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Intracerebral hemorragheNo interventionPatients that suffered an intracerebral hemorraghe and that have been subjected to CT and MRI scans
Primary Outcome Measures
NameTimeMethod
Hematoma growth2 days

Difference of hematoma size between CT conducted at admission and MRI conducted during follow up

Correlation between hematoma growth and analytical parameters2 days

Determine the analytical parameters related with hematoma growth

Correlation between clinical parameters and the size of alterations in DWI2 days

Determine the relationship between clinical parameters and the size of alterations in DWI

Alterations in DWI2 days

Size of alterations in diffusion weighted image

Correlation between analytical parameters and the size of alterations in DWI2 days

Determine the relationship between analytical parameters and the size of alterations in DWI

Correlation between hematoma growth and clinical paramenters2 days

Determine the clinical parameters related with hematoma growth

Correlation between perilesional edema size and clinical outcome1 month

Determine the relationship between the size of edema and clinical outcome

Perilesional edema2 days

Size of edema measured in FLAIR sequences

Correlation between clinical parameters and the size of edema measured in FLAIR sequences2 days

Determine the relationship between clinical parameters and the size of edema

Correlation between analytical parameters and the size of edema measured in FLAIR sequences2 days

Determine the relationship between analytical parameters and the size of edema

Correlation between hematoma growth and clinical outcome1 month

Determine the impact of hematoma growth on clinical outcome

Correlation between the clinical parameters and clinical outcome1 month

Determine the relationship between the clinical parametes and clinical outcome

Correlation between the analyticial parameters and clinical outcome1 month

Determine the relationship between the analytical parametes and clinical outcome

Correlation between the size of DWI alterations and clinical outcome1 month

Determine the relationship between the size of DWI alterations and clinical outcome

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Santiago Rojas Codina MD PhD

🇪🇸

Cerdanyola del Valles, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath